Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
- 1 August 1986
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 24 (2) , 197-202
- https://doi.org/10.1128/jcm.24.2.197-202.1986
Abstract
The serum antibody response of infants and children immunized with Formalin-inactivated respiratory syncytial virus (RSV) vaccine 20 years ago was determined by using an enzyme-linked immunosorbent assay specific for the RSV fusion (F) and large (G) glycoproteins and a neutralization assay. Twenty-one young infants (2 to 6 months of age) developed a high titer of antibodies to the F glycoprotein but had a poor response to the G glycoprotein. Fifteen older individuals (7 to 40 months of age) developed titers of F and G antibodies comparable to those in children who were infected with RSV. However, both immunized infants and children developed a lower level of neutralizing antibodies than did individuals of comparable age with natural RSV infections. Thus, the treatment of RSV with Formalin appears to have altered the epitopes of the F or G glycoproteins or both that stimulate neutralizing antibodies, with the result that the immune response consisted largely of "nonfunctional" (i.e., nonneutralizing) antibodies. Subsequent natural infection of the vaccinees with wild-type RSV resulted in enhanced pulmonary disease. Despite this potentiation of illness, the infected vaccinees developed relatively poor G, F, and neutralizing antibody responses. Any or all of three factors may have contributed to the enhancement of disease in the RSV-infected vaccinees. First, nonfunctional antibodies induced by the inactivated RSV vaccine may have participated in a pulmonary Arthus reaction during RSV infection. Second, the poor antibody response of infants to the G glycoprotein present in the Formalin-inactivated vaccine may have been inadequate to provide effective resistance to subsequent wildtype virus infection. Third, the relatively reduced neutralizing antibody response of the infant vaccinees to wild-type RSV infection may have contributed to their enhanced disease by delaying the clearance of virus from their lungs.This publication has 21 references indexed in Scilit:
- Purification and Characterization of the Respiratory Syncytial Virus Fusion ProteinJournal of General Virology, 1985
- Purification and Characterization of GP90, One of the Envelope Glycoproteins of Respiratory Syncytial VirusJournal of General Virology, 1984
- Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.The Journal of Experimental Medicine, 1980
- Differences in Antibodies to the Surface Components of Mumps Virus after Immunization with Formalin-Inactivated and Live Virus VaccinesThe Journal of Infectious Diseases, 1978
- Immunologic Properties of Purified Sendai Virus GlycoproteinsThe Journal of Immunology, 1977
- Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by InfectionPediatric Research, 1976
- Differences in the Appearance of Antibodies to Structural Components of Measles Virus after Immunization with Inactivated and Live VirusThe Journal of Infectious Diseases, 1975
- BIOLOGIC SIGNIFICANCE OF THE SECRETORY γA IMMUNOGLOBULINSPediatrics, 1971
- Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.1971
- Measles Immunization With Killed Virus VaccineAmerican Journal of Diseases of Children, 1965